Published in AIDS on May 23, 2017
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol (2005) 8.77
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr (2002) 7.79
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat (2012) 5.35
Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99
Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J Natl Cancer Inst (1997) 2.61
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med (2016) 2.02
Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS (2003) 1.88
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS (2007) 1.70
Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65
Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr (2003) 1.44
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011. BJOG (2013) 1.44
Ventricular septal defect. Lancet (2011) 1.43
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS (1998) 1.40
Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS (2009) 1.36
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr (2000) 1.20
Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf (2014) 1.19
Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11). PLoS Med (2014) 1.16
Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. J Acquir Immune Defic Syndr (2010) 1.10
Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals. Pediatrics (2004) 1.10
Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr (2007) 1.07
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J (2012) 1.06
Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. J Perinat Med (2010) 1.05
Prenatal zidovudine use and congenital anomalies in a medicaid population. J Acquir Immune Defic Syndr (2000) 1.05
Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children < or = 5 years of age, Pediatric Spectrum of HIV Disease project (PSD), USA. Ann N Y Acad Sci (2000) 1.00
Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ (2015) 1.00
Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study. Ann N Y Acad Sci (2000) 0.98
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr (2011) 0.94
Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. JAMA Psychiatry (2016) 0.90
Drug safety during pregnancy and in infants. Lack of mortality related to mitochondrial dysfunction among perinatally HIV-exposed children in pediatric HIV surveillance. Ann N Y Acad Sci (2000) 0.89
Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants. JAMA Pediatr (2015) 0.87
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. Clin Infect Dis (2015) 0.82
Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results. Pharmacoepidemiol Drug Saf (2015) 0.81
First trimester exposure to antiretroviral therapy and risk of birth defects. Pediatr Infect Dis J (2014) 0.80
Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry. Eur J Obstet Gynecol Reprod Biol (2015) 0.77
Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia. Pediatrics (2016) 0.76
Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009. BMC Infect Dis (2014) 0.75
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. N Engl J Med (2005) 8.49
Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 5.91
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med (2006) 5.53
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis (2009) 3.89
Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88
Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology (2006) 3.71
Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr (2005) 3.54
Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37
Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med (2013) 3.10
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr (2010) 2.96
Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA (2006) 2.96
Estimating the lost benefits of antiretroviral drug use in South Africa. J Acquir Immune Defic Syndr (2008) 2.93
The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int (2004) 2.88
Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect (2008) 2.75
Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol (2014) 2.67
Randomized, controlled evaluation of a prototype informed consent process for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr (2003) 2.60
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med (2003) 2.48
HIV incidence determination in the United States: a multiassay approach. J Infect Dis (2012) 2.47
Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect (2012) 2.43
Polymorphisms in the mannose binding lectin-2 gene and acute respiratory distress syndrome. Crit Care Med (2007) 2.31
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28
Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS (2012) 2.19
Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents. AIDS (2009) 2.16
Intimate partner violence functions as both a risk marker and risk factor for women's HIV infection: findings from Indian husband-wife dyads. J Acquir Immune Defic Syndr (2009) 2.15
An application of propensity score matching using claims data. Pharmacoepidemiol Drug Saf (2005) 2.15
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology (2013) 2.06
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol (2017) 2.05
Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg (2014) 2.04
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis (2003) 2.04
Violence victimisation, sexual risk and sexually transmitted infection symptoms among female sex workers in Thailand. Sex Transm Infect (2010) 2.02
Syphilis and hepatitis B Co-infection among HIV-infected, sex-trafficked women and girls, Nepal. Emerg Infect Dis (2008) 1.97
Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect (2012) 1.96
Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. JAMA (2005) 1.91
Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*. Crit Care Med (2013) 1.90
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women. Clin Infect Dis (2012) 1.80
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics (2009) 1.79
Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol (2005) 1.78
Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77
Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS (2007) 1.70
Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann Emerg Med (2007) 1.66
Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS (2011) 1.66
Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65
Development and validation of a score for prediction of postoperative respiratory complications. Anesthesiology (2013) 1.62
Serum concentrations of polychlorinated biphenyls in relation to in vitro fertilization outcomes. Environ Health Perspect (2011) 1.60
Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60
Delayed onset of pubertal development in children and adolescents with perinatally acquired HIV infection. J Acquir Immune Defic Syndr (2003) 1.60
Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res (2005) 1.60
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine. Birth Defects Res B Dev Reprod Toxicol (2004) 1.57
Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med (2005) 1.56
Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes. J Acquir Immune Defic Syndr (2011) 1.55
Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis (2004) 1.54
Emergency department patient acceptance of opt-in, universal, rapid HIV screening. Public Health Rep (2009) 1.54
Preoperative Opioid Misuse is Associated With Increased Morbidity and Mortality After Elective Orthopaedic Surgery. Clin Orthop Relat Res (2015) 1.53
Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol (2005) 1.53
Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53
Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care (2011) 1.51
Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol (2012) 1.51
Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One (2011) 1.50
Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes. Anesthesiology (2014) 1.50
Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod (2012) 1.48
Maternal urinary metabolites of Di-(2-Ethylhexyl) phthalate in relation to the timing of labor in a US multicenter pregnancy cohort study. Am J Epidemiol (2009) 1.47
Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One (2011) 1.46
The effect of antiretroviral therapy on secondary transmission of HIV among men who have sex with men. Clin Infect Dis (2007) 1.43
Cardiac arrest during hospitalization for delivery in the United States, 1998-2011. Anesthesiology (2014) 1.43
Triggers of spontaneous preterm delivery--why today? Paediatr Perinat Epidemiol (2014) 1.42
Challenges in using observational studies to evaluate adverse effects of treatment. N Engl J Med (2007) 1.42
Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence. Pediatr Infect Dis J (2012) 1.41
Genetic modification of the association between peripubertal dioxin exposure and pubertal onset in a cohort of Russian boys. Environ Health Perspect (2012) 1.39
The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology (2002) 1.38
Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. J Dev Behav Pediatr (2010) 1.36
HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission. PLoS One (2010) 1.36
Urinary bisphenol A concentrations and implantation failure among women undergoing in vitro fertilization. Environ Health Perspect (2012) 1.34
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. Am J Epidemiol (2008) 1.31
The role of cognitive functioning in medication adherence of children and adolescents with HIV infection. J Pediatr Psychol (2008) 1.30
A propensity score-matched cohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocardial infarction. Am J Cardiol (2003) 1.29
Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol (2011) 1.28
Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27
Influence of patient comorbidities on the risk of near-miss maternal morbidity or mortality. Anesthesiology (2011) 1.26
In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STDS (2011) 1.26